CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chongqing Lummy Pharmaceutical Co Ltd Company Snapshot
Chongqing Lummy Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Lummy Pharmaceutical Co Ltd with three other companies in this sector in China: Henan Taloph Pharmaceutical Stock Company Limited (2016 sales of 953.31 million Chinese Renmimbi [US$138.36 million] of which 68% was Medicine Manufacturing), Autobio Diagnostics Co Ltd (980.22 million Chinese Renmimbi [US$142.27 million] of which 95% was In vitro diagnosis), and Zhejiang Shapuaisi Pharmaceutical Co Ltd (978.73 million Chinese Renmimbi [US$142.05 million] of which 98% was Medicine Industry - Chemical pharmaceuti).

Sales Analysis. During the year ended December of 2016, sales at Chongqing Lummy Pharmaceutical Co Ltd were 990.18 million Chinese Renmimbi (US$143.71 million). This is an increase of 2.7% versus 2015, when the company's sales were 963.85 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Chongqing Lummy Pharmaceutical Co Ltd (and since 2011, sales have increased a total of 85%). Sales of Chemical Manufacturing saw an increase that was more than double the company's growth rate: sales were up 7.6% in 2016, from 901.47 million Chinese Renmimbi to 969.84 million Chinese Renmimbi. Not all segments of Chongqing Lummy Pharmaceutical Co Ltd experienced an increase in sales in 2016: sales of Other Operations fell 86.7% to 1.15 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Chongqing Lummy Pharmaceutical Co Ltd also experienced decreases in sales in Chemical Distribution (down 64.3% to 19.23 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chongqing Lummy Pharmaceutical Co Ltd
  Stock Performance Chart for Chongqing Lummy Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): 6.15
(Figures in Chinese Renmimbi)
1 Week -3.9%   13 Weeks -14.0%  
4 Weeks -29.5%   52 Weeks -30.8%  
 
Chongqing Lummy Pharmaceutical Co Ltd Key Data:
  Ticker: 300006 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 990,176,102
(Year Ending Jan 2017).
Employees: 1,514
  Currency: Chinese Renmimbi Market Cap: 4,995,283,411
  Fiscal Yr Ends: December Shares Outstanding: 812,241,205
  Share Type: Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.